Argiris S. Symeonidis
Patra, ESYE23 26504, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
RNA and Mitochondrial Reprogramming Associated with Azacytidine Treatment in Higher-Risk Myelodysplastic Syndromes: A Pilot Study.
Journal: Cancers
Published: June 18, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 16, 2026
Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.
Journal: Acta haematologica
Published: September 05, 2025
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.
Journal: British journal of haematology
Published: September 03, 2025
Intracellular Mis-Localization of Modified RNA Molecules and Non-Coding RNAs: Facts from Hematologic Malignancies.
Journal: Current issues in molecular biology
Published: July 18, 2025
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.
Journal: European journal of haematology
Published: July 14, 2025
The Transcription Axes ERK-Elk1, JNK-cJun, and JAK-STAT Promote Autophagy Activation and Proteasome Inhibitor Resistance in Prostate Cancer Cells.
Journal: Current issues in molecular biology
Published: April 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).
Journal: Cancers
Published: February 28, 2025
Editorial: MDS: new scientific and clinical developments.
Journal: Frontiers in oncology
Published: January 30, 2025
Last Updated: 09/26/2026